0 XP   0   0   0

Vera Therapeutics Inc
Buy, Hold or Sell?

I guess you are interested in Vera Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Vera Therapeutics Inc

Let's start. I'm going to help you getting a better view of Vera Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Vera Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Vera Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Vera Therapeutics Inc. The closing price on 2022-09-30 was $21.31 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Vera Therapeutics Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Vera Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Vera Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY--342.1%+342.1%
5Y--475.7%+475.7%
10Y--561.7%+561.7%
1.1.2. Return on Assets

Shows how efficient Vera Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • -12.2% Return on Assets means that Vera Therapeutics Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vera Therapeutics Inc:

  • The MRQ is -10.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.0%TTM-12.2%+2.2%
TTM-12.2%YOY-30.4%+18.2%
TTM-12.2%5Y-20.0%+7.8%
5Y-20.0%10Y-20.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.0%-9.7%-0.3%
TTM-12.2%-8.7%-3.5%
YOY-30.4%-9.2%-21.2%
5Y-20.0%-11.5%-8.5%
10Y-20.0%-12.4%-7.6%
1.1.3. Return on Equity

Shows how efficient Vera Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • -12.2% Return on Equity means the company generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vera Therapeutics Inc:

  • The MRQ is -12.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.2%TTM-14.5%+2.3%
TTM-14.5%YOY-1.2%-13.3%
TTM-14.5%5Y-8.8%-5.7%
5Y-8.8%10Y-8.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-11.8%-0.4%
TTM-14.5%-11.1%-3.4%
YOY-1.2%-10.6%+9.4%
5Y-8.8%-13.5%+4.7%
10Y-8.8%-14.5%+5.7%

1.2. Operating Efficiency of Vera Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vera Therapeutics Inc is operating .

  • Measures how much profit Vera Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vera Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY--309.3%+309.3%
5Y--466.7%+466.7%
10Y--572.5%+572.5%
1.2.2. Operating Ratio

Measures how efficient Vera Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.542-3.542
YOY-3.491-3.491
5Y-5.744-5.744
10Y-7.007-7.007

1.3. Liquidity of Vera Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 823.8% means the company has $8.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 8.238. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.269. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.238TTM12.269-4.032
TTM12.269YOY20.569-8.300
TTM12.2695Y15.826-3.557
5Y15.82610Y15.8260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2385.266+2.972
TTM12.2696.060+6.209
YOY20.5696.366+14.203
5Y15.8266.692+9.134
10Y15.8266.457+9.369
1.3.2. Quick Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 1,235.2% means the company can pay off $12.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 12.352. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.449. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.352TTM13.449-1.097
TTM13.449YOY12.634+0.815
TTM13.4495Y13.100+0.349
5Y13.10010Y13.1000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3524.055+8.297
TTM13.4494.865+8.584
YOY12.6345.192+7.442
5Y13.1005.275+7.825
10Y13.1004.997+8.103

1.4. Solvency of Vera Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vera Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.18 means that Vera Therapeutics Inc assets are financed with 18.3% credit (debt) and the remaining percentage (100% - 18.3%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.183. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.150. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.183TTM0.150+0.033
TTM0.150YOY1.832-1.682
TTM0.1505Y0.871-0.721
5Y0.87110Y0.8710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1830.271-0.088
TTM0.1500.269-0.119
YOY1.8320.296+1.536
5Y0.8710.361+0.510
10Y0.8710.399+0.472
1.4.2. Debt to Equity Ratio

Measures if Vera Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 22.5% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.225. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.180. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.225TTM0.180+0.044
TTM0.180YOY0.020+0.161
TTM0.1805Y0.112+0.069
5Y0.11210Y0.1120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2250.310-0.085
TTM0.1800.311-0.131
YOY0.0200.310-0.290
5Y0.1120.382-0.270
10Y0.1120.438-0.326

2. Market Valuation of Vera Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Vera Therapeutics Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -5.66 means the investor is paying $-5.66 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vera Therapeutics Inc:

  • The EOD is -8.866. Company is losing money. -2
  • The MRQ is -5.663. Company is losing money. -2
  • The TTM is -9.003. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-8.866MRQ-5.663-3.204
MRQ-5.663TTM-9.003+3.340
TTM-9.003YOY--9.003
TTM-9.0035Y-5.144-3.858
5Y-5.14410Y-5.1440.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.866-2.115-6.751
MRQ-5.663-2.332-3.331
TTM-9.003-3.889-5.114
YOY--5.087+5.087
5Y-5.144-3.697-1.447
10Y-5.144-3.390-1.754

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Vera Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.03 means the investor is paying $3.03 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vera Therapeutics Inc:

  • The EOD is 4.749. Neutral. Compare to industry.
  • The MRQ is 3.033. Neutral. Compare to industry.
  • The TTM is 4.938. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.749MRQ3.033+1.716
MRQ3.033TTM4.938-1.905
TTM4.938YOY0.504+4.434
TTM4.9385Y3.038+1.900
5Y3.03810Y3.0380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.7491.843+2.906
MRQ3.0331.961+1.072
TTM4.9382.789+2.149
YOY0.5043.538-3.034
5Y3.0382.782+0.256
10Y3.0382.419+0.619

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vera Therapeutics Inc.

3.1. Institutions holding Vera Therapeutics Inc

Institutions are holding 92.1% of the shares of Vera Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31FMR Inc14.80590.0075401203086682827.5603
2022-03-31Sofinnova Ventures11.74075.671931814422666669.1488
2022-03-31Abingworth LLP10.924419.6596296023100
2022-03-31Citadel Advisors Llc7.71110.0101208952035633820.5598
2022-03-31RA Capital Management, LLC7.25561.0077196608419660840
2022-06-30Kynam Capital Management, LP5.61945.292415227121020384203.131
2022-06-30Vivo Capital, LLC2.46020.911166666600
2022-03-31Vanguard Group Inc2.28070.000361800322902558.8787
2022-06-30Octagon Capital Advisors LP2.1222.088657500000
2022-06-30Baker Bros Advisors LP1.23010.025733333300
2022-06-30Geode Capital Management, LLC0.7550.000420458820411.0077
2022-03-31International Biotechnology Trust PLC0.70392.6191907497021458.252
2022-03-31State Street Corporation0.62280.00021687574548436.897
2022-03-31JPMorgan Chase & Co0.55210.00041496017347596.5176
2022-03-31Millennium Management LLC0.49270.00171335001335000
2022-03-31Northern Trust Corp0.40380.00051094073155440.5302
2022-03-31MAVEN SECURITIES Ltd0.23710.052564240642400
2022-03-31Polar Asset Management Partners0.22140.015160000600000
2022-03-31Nuveen Asset Management, LLC0.19790.00045362338525255.1662
2022-03-31Bank of New York Mellon Corp0.18020.00024883628247137.1946
Total 70.51737.365319108322  

3.2. Funds holding Vera Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Fidelity Advisor® Biotechnology I3.61830.833898046800
2022-06-30Fidelity® Select Biotechnology2.87760.218577976800
2022-06-30Fidelity Growth Compy Commingled Pl 32.47790.01967145215910.2375
2022-06-30Fidelity® Growth Company2.13470.0192578448-3454-0.5936
2022-05-31Fidelity® Series Small Cap Opps2.0360.156855170000
2022-07-31Vanguard Total Stock Mkt Idx Inv1.51230.000640978500
2022-06-30International Biotechnology Ord1.03721.12212810579030847.3439
2022-07-29iShares Russell 2000 ETF1.03250.0092797882450.0876
2022-05-31Fidelity® Stock Selector Small Cap0.75280.147920400000
2022-06-30Fidelity® Series Growth Company0.46930.015712718200
2022-07-31Vanguard Extended Market Index Investor0.45230.002412255010360.8526
2022-06-30Fidelity® Growth Company K60.44930.01712175018631.554
2022-05-31Fidelity® Small Cap Index0.38760.008110503400
2022-07-29iShares Russell 2000 Growth ETF0.36440.017398756-115-0.1163
2022-07-31State St Russell Sm/Mid Cp® Indx NL Cl C0.25570.00366928900
2022-07-31State St Russell Sm Cap® Indx NL Cl C0.18410.00944988800
2022-07-31Vanguard Health Care ETF0.18090.0043490214961.0222
2022-06-30Fidelity® Extended Market Index0.17860.00234839300
2022-06-30NT R2000 Index Fund - NL0.14550.0082394341710.4355
2022-06-30NT R2000 Growth Index Fund - NL0.13740.0148372271384759.2258
Total 20.68442.635604990  

3.3. Insider Transactions

Insiders are holding 8.747% of the shares of Vera Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-22Joanne CurleySELL163018.8729785
2022-08-19Joanne CurleySELL690919.229785
2022-08-17Carlyle Group Inc.SELL992520.252960231
2022-08-12Marshall FordyceSELL2052820.16137400
2022-08-03Joanne CurleySELL98816.8117285
2022-07-19Joanne CurleySELL1144416.0118273
2022-07-14Joanne CurleySELL910415.1418273
2022-07-07Joanne CurleySELL966615.0521023
2022-06-22Joanne CurleySELL154515.0123688
2022-06-17Joanne CurleySELL588715.0423994
2022-06-15Sean GrantBUY500013.62816
2022-02-10Patrick G EnrightBUY33333315
2022-02-10Sofinnova Venture Partners X,BUY26666615
2021-05-18Llp AbingworthBUY77272711 

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vera Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--4.4874.331+4%-0.048+101%2.455+83%2.455+83%
Book Value Per Share Growth---1.061-1.072+1%2.926-136%0.641-266%0.641-266%
Current Ratio--8.23812.269-33%20.569-60%15.826-48%15.826-48%
Debt To Asset Ratio--0.1830.150+22%1.832-90%0.871-79%0.871-79%
Debt To Equity Ratio--0.2250.180+24%0.020+1030%0.112+101%0.112+101%
Dividend Per Share----0%-0%-0%-0%
Eps---0.549-0.601+10%-0.924+68%-0.739+35%-0.739+35%
Gains Per Share---1.061-1.072+1%2.926-136%0.641-266%0.641-266%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio4.749+36%3.0334.938-39%0.504+502%3.0380%3.0380%
Pe Ratio-8.866-57%-5.663-9.003+59%--100%-5.144-9%-5.144-9%
Price Per Share21.310+36%13.61020.293-33%4.420+208%13.490+1%13.490+1%
Quick Ratio--12.35213.449-8%12.634-2%13.100-6%13.100-6%
Return On Assets---0.100-0.122+22%-0.304+205%-0.200+100%-0.200+100%
Return On Equity---0.122-0.145+19%-0.012-90%-0.088-28%-0.088-28%
 EOD+1 -2MRQTTM+8 -5YOY+5 -85Y+6 -710Y+6 -7

4.2. Fundamental Score

Let's check the fundamental score of Vera Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.866
Price to Book Ratio (EOD)Between0-14.749
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than112.352
Current Ratio (MRQ)Greater than18.238
Debt to Asset Ratio (MRQ)Less than10.183
Debt to Equity Ratio (MRQ)Less than10.225
Return on Equity (MRQ)Greater than0.15-0.122
Return on Assets (MRQ)Greater than0.05-0.100
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.414
Ma 20Greater thanMa 5020.930
Ma 50Greater thanMa 10019.764
Ma 100Greater thanMa 20017.236
OpenGreater thanClose20.820
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Reconciled Depreciation  50959-2732-239-115-106
Depreciation and Amortization  50959-2732-239-115-106



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets148,782
Total Liabilities27,278
Total Stockholder Equity121,504
 As reported
Total Liabilities 27,278
Total Stockholder Equity+ 121,504
Total Assets = 148,782

Assets

Total Assets148,782
Total Current Assets142,338
Long-term Assets142,338
Total Current Assets
Cash And Cash Equivalents 50,427
Short-term Investments 81,501
Other Current Assets 10,410
Total Current Assets  (as reported)142,338
Total Current Assets  (calculated)142,338
+/-0
Long-term Assets
Property Plant Equipment 5,745
Long Term Investments 324
Other Assets 375
Long-term Assets  (as reported)6,444
Long-term Assets  (calculated)6,444
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,279
Long-term Liabilities9,999
Total Stockholder Equity121,504
Total Current Liabilities
Short-term Debt 2,450
Accounts payable 7,084
Other Current Liabilities 7,745
Total Current Liabilities  (as reported)17,279
Total Current Liabilities  (calculated)17,279
+/-0
Long-term Liabilities
Long term Debt Total 4,952
Capital Lease Obligations Min Short Term Debt4,761
Other Liabilities 286
Long-term Liabilities  (as reported)9,999
Long-term Liabilities  (calculated)9,999
+/-0
Total Stockholder Equity
Common Stock27
Retained Earnings -155,994
Accumulated Other Comprehensive Income -152
Capital Surplus 277,623
Total Stockholder Equity (as reported)121,504
Total Stockholder Equity (calculated)121,504
+/-0
Other
Capital Stock27
Cash and Short Term Investments 131,928
Common Stock Shares Outstanding 27,078
Common Stock Total Equity27
Liabilities and Stockholders Equity 148,782
Net Debt -38,264
Net Invested Capital 126,456
Net Tangible Assets 121,504
Net Working Capital 125,059
Short Long Term Debt Total 12,163



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
54,554
51,825
97,647
91,167
83,748
164,974
148,782
148,782164,97483,74891,16797,64751,82554,554000
   > Total Current Assets 
0
0
0
54,261
51,532
95,876
89,760
82,537
157,743
142,338
142,338157,74382,53789,76095,87651,53254,261000
       Cash And Cash Equivalents 
0
0
0
53,654
49,505
91,625
86,191
79,674
111,506
50,427
50,427111,50679,67486,19191,62549,50553,654000
       Short-term Investments 
0
0
0
0
0
1,478
0
867
39,432
81,501
81,50139,43286701,47800000
       Net Receivables 
0
0
0
52
0
0
0
0
0
0
00000052000
       Other Current Assets 
0
0
0
442
2,027
4,251
3,569
1,996
6,805
10,410
10,4106,8051,9963,5694,2512,027442000
   > Long-term Assets 
0
0
0
293
293
1,771
1,407
1,211
7,231
6,444
6,4447,2311,2111,4071,771293293000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
6,291
5,745
5,7456,29100000000
       Long Term Investments 
0
0
0
0
0
1,478
1,114
867
580
324
3245808671,1141,47800000
       Other Assets 
0
0
0
293
293
293
293
344
360
375
375360344293293293293000
> Total Liabilities 
0
0
0
143,902
145,141
5,492
5,690
14,156
30,549
27,278
27,27830,54914,1565,6905,492145,141143,902000
   > Total Current Liabilities 
0
0
0
2,406
3,753
3,771
4,042
7,690
19,969
17,279
17,27919,9697,6904,0423,7713,7532,406000
       Short-term Debt 
0
0
0
0
0
0
0
0
2,490
2,450
2,4502,49000000000
       Accounts payable 
0
0
0
909
1,440
1,723
964
1,385
7,328
7,084
7,0847,3281,3859641,7231,440909000
       Other Current Liabilities 
0
0
0
962
2,313
2,048
3,078
6,305
10,151
7,745
7,74510,1516,3053,0782,0482,313962000
   > Long-term Liabilities 
0
0
0
141,496
141,388
1,721
1,648
6,466
10,580
9,999
9,99910,5806,4661,6481,721141,388141,496000
       Long term Debt Total 
0
0
0
0
0
0
0
4,923
4,937
4,952
4,9524,9374,9230000000
       Warrants
0
0
0
0
139,576
139,576
0
0
0
0
0000139,576139,5760000
       Other Liabilities 
0
0
0
1,920
1,812
1,721
1,648
1,543
286
286
2862861,5431,6481,7211,8121,920000
> Total Stockholder Equity
0
0
0
-89,348
-93,316
92,155
85,477
69,592
134,425
121,504
121,504134,42569,59285,47792,155-93,316-89,348000
   Common Stock
0
0
0
0
0
21
21
21
27
27
272721212100000
   Retained Earnings Total Equity-155,994-141,141-124,056-107,209-96,161-96,1610000
   Accumulated Other Comprehensive Income -152-1200000000
   Capital Surplus 
0
0
0
0
2,845
2,845
192,665
193,627
275,551
277,623
277,623275,551193,627192,6652,8452,8450000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
0
0
191,732
192,665
193,627
275,551
277,623
277,623275,551193,627192,665191,73200000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-34,402
Operating Income-34,402-34,402
 
Operating Expense (+$)
Research Development22,484
Selling General Administrative11,918
Selling And Marketing Expenses-
Operating Expense34,40234,402
 
Net Interest Income (+$)
Interest Income15
Interest Expense-20
Net Interest Income-5-5
 
Pretax Income (+$)
Operating Income-34,402
Net Interest Income-5
Other Non-Operating Income Expenses1,814
Income Before Tax (EBT)-32,608-36,196
EBIT - interestExpense = -32,608
-32,608
-32,587
Interest Expense20
Earnings Before Interest and Taxes (ebit)-32,588-32,588
Earnings Before Interest and Taxes (ebitda)-32,412
 
After tax Income (+$)
Income Before Tax-32,608
Tax Provision-1
Net Income From Continuing Ops-32,609-32,609
Net Income-32,607
Net Income Applicable To Common Shares-32,609
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1,794-1,809
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
5 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
5 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
5 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
5 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
5 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
5 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
5 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
5 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
5 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart